Cargando…

The Estimated Lifetime Quality-Adjusted Life-Years Lost Due to Chlamydia, Gonorrhea, and Trichomoniasis in the United States in 2018

BACKGROUND: Comprehensive evaluation of the quality-adjusted life-years (QALYs) lost attributable to chlamydia, gonorrhea, andtrichomoniasis in the United States is lacking. METHODS: We adapted a previous probability-tree model to estimate the average number of lifetime QALYs lost due to genital chl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yunfei, You, Shiying, Lee, Kyueun, Yaesoubi, Reza, Hsu, Katherine, Gift, Thomas L, Chesson, Harrell W, Berruti, Andrés A, Salomon, Joshua A, Rönn, Minttu M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112678/ https://www.ncbi.nlm.nih.gov/pubmed/36806950 http://dx.doi.org/10.1093/infdis/jiad047

Ejemplares similares

Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Due to Syphilis Acquired in the United States in 2018
por: Lee, Kyueun, et al.
Publicado: (2022)

Lifetime quality-adjusted life years lost due to genital herpes acquired in the United States in 2018: a mathematical modeling study
por: You, Shiying, et al.
Publicado: (2023)

Estimated Impact of Screening on Gonorrhea Epidemiology in the United States: Insights From a Mathematical Model
por: Tuite, Ashleigh R, et al.
Publicado: (2018)

Costs, Health Benefits, and Cost-Effectiveness of Chlamydia Screening and Partner Notification in the United States, 2000–2019: A Mathematical Modeling Analysis
por: Rönn, Minttu M., et al.
Publicado: (2023)

Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea
por: Tuite, Ashleigh R, et al.
Publicado: (2017)

Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors
por: Li, Yunfei, et al.
Publicado: (2022)

Resistance-minimizing strategies for introducing a novel antibiotic for gonorrhea treatment: a mathematical modeling study
por: Reichert, E, et al.
Publicado: (2023)

Public willingness to receive chlamydia, gonorrhea, syphilis, and trichomoniasis vaccines: a scoping review
por: Valleroy, T., et al.
Publicado: (2023)

Modeling the Cost-Effectiveness of Express Multisite Gonorrhea Screening Among Men Who Have Sex With Men in the United States
por: Earnest, Rebecca, et al.
Publicado: (2021)

Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study
por: Yaesoubi, Reza, et al.
Publicado: (2020)

The Use of Mathematical Models of Chlamydia Transmission to Address Public Health Policy Questions: A Systematic Review
por: Rönn, Minttu M., et al.
Publicado: (2017)

Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis
por: Rönn, Minttu M, et al.
Publicado: (2020)

The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000–2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model
por: Rönn, Minttu M, et al.
Publicado: (2019)

The Potential Population-Level Impact of Different Gonorrhea Screening Strategies in Baltimore and San Francisco: An Exploratory Mathematical Modeling Analysis
por: Rönn, Minttu M., et al.
Publicado: (2020)

Anatomic Site–Specific Gonorrhea and Chlamydia Testing and Incidence Among People With HIV Engaged in Care at 4 US Clinical Centers, 2014–2018
por: Menza, Timothy W, et al.
Publicado: (2022)

Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
por: Chesson, Harrell W., et al.
Publicado: (2014)

Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics
por: Yaesoubi, Reza, et al.
Publicado: (2022)

A Missed Opportunity: Extragenital Screening for Gonorrhea and Chlamydia Sexually Transmitted Infections in People With HIV in a Southeastern Ryan White HIV/AIDS Program Clinic Setting
por: Geba, Maria C, et al.
Publicado: (2022)

Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016
por: Rowley, Jane, et al.
Publicado: (2019)

Chlamydia and Gonorrhea: Shifting Age-Based Positivity Among Young Females, 2010–2017
por: Kaufman, Harvey W., et al.
Publicado: (2020)

Syphilis Testing among Men Who Have Had Rectal Gonorrhea and Chlamydia Tests, United States
por: Tao, Guoyu, et al.
Publicado: (2019)

Cost-effectiveness of Chlamydia Vaccination Programs for Young Women
por: Owusu-Edusei, Kwame, et al.
Publicado: (2015)

Trichomoniasis: An update
por: Preethi, V, et al.
Publicado: (2011)

Vaginal trichomoniasis
por: Cenkowski, Monica, et al.
Publicado: (2022)

Screening for Syphilis in Cases of Suspected Gonorrhea and Chlamydia Infections
por: Nibhanipudi, Kumara V., et al.
Publicado: (2017)

A practical approach to the diagnosis and management of chlamydia and gonorrhea
por: Van Ommen, Clara E., et al.
Publicado: (2023)

Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communities
por: Rönn, Minttu M., et al.
Publicado: (2020)

Accuracy of ICD Codes for Identification: Review of Chlamydia, Gonorrhea and Syphilis
por: Ho, Yenling A., et al.
Publicado: (2019)

Evaluation of chlamydia and gonorrhea electronic provider reports data quality
por: Tseng, Marion, et al.
Publicado: (2017)

Evaluation of the Performance of a Point-of-Care Test for Chlamydia and Gonorrhea
por: Van Der Pol, Barbara, et al.
Publicado: (2020)

Screening for chlamydia and gonorrhea in primary care in populations with low prevalence
por: Whellams, Diana
Publicado: (2021)

Impact of the COVID-19 Pandemic on Chlamydia and Gonorrhea Screening in the U.S.
por: Pinto, Casey N., et al.
Publicado: (2021)

Optimizing Coverage vs Frequency for Sexually Transmitted Infection Screening of Men Who Have Sex With Men
por: Weiss, Kevin M, et al.
Publicado: (2019)

Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996–2016
por: Carstensen, Bendix, et al.
Publicado: (2021)

Chlamydia and Gonorrhea Infections in HIV-positive Women in Urban Lusaka, Zambia
por: Alcaide, Maria L, et al.
Publicado: (2012)

Screening for chlamydia and/or gonorrhea in primary health care: protocol for systematic review
por: Pillay, Jennifer, et al.
Publicado: (2018)

963. Extragenital Chlamydia and Gonorrhea Among Females Visiting an STD Clinic
por: Maynard, Michaela, et al.
Publicado: (2019)

Availability of Extragenital Chlamydia and Gonorrhea Testing in 6 High-Incidence States
por: Vu, Kathy Linh, et al.
Publicado: (2023)

Trichomoniasis and Lactoferrin: Future Prospects
por: Sehgal, Rakesh, et al.
Publicado: (2012)

Cost-Effective Screening for Trichomoniasis
por: Schwebke, Jane R.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_p3fmhban407lpdq3nbkbf42m1s